Ellen Jo Baron, Ph.D., was the director of the clinical microbiology/virology laboratories at Stanford University Medical Center for 15 years before joining Cepheid, a molecular diagnostics manufacturer in 2009, where she is now executive director of medical affairs. She has been a board-certified clinical microbiology laboratory director for more than 30 years. Her basic microbiology flowchart system is in use in laboratories throughout the world. She was bacteriology editor for the American Society for Microbiology (ASM) Manual of Clinical Microbiology for four editions and also edited the Infectious Diseases Society of America and ASM “Guideline on Infectious Diseases Diagnostic Testing.” She has written or edited more than 30 books and chapters and more than 100 journal articles about infectious diseases diagnostics. She received the Stanford Medicine Lifetime Achievement Award, as well as the ASM bioMérieux Sonnenwirth Award for Leadership in Clinical Microbiology, ASM Alice Evans Award for serving as a role model for women in microbiology, and ASM Founders Distinguished Service Award in 2012. She has been an invited speaker throughout the world at more than 300 conferences and symposia. She is the co-founder of the Diagnostic Microbiology Development Program, a nongovernmental organization that does laboratory capacity building in the developing world, with major activities in Cambodia.
Franck Berthe, D.V.M., Ph.D., is a senior livestock specialist in the Agriculture Global Practice of the World Bank and coordinator of the Livestock Global Alliance since March 2016. The Alliance brings together the Food and Agriculture Organization of the United Nations, the International Fund
for Agriculture Development, the International Research Institute on Livestock (ILRI/CGIAR), the World Organisation for Animal Health (OIE), and the World Bank, five global public institutions committed for safer, fairer, and more sustainable livestock. Dr. Berthe was previously head of the Animal and Plant Health Unit at the European Food Safety Authority based in Parma, Italy. His core activity was to assess animal and plant production systems and practices with respect to primary production, ecosystems, and public health. Dr. Berthe’s job was to provide scientific advice to the EU risk managers and decision makers on a wide range of risks at the human–animal–ecosystem interface. Prior to coming to Italy in 2007, Dr. Berthe was associate professor at the Atlantic Veterinary College (UPEI) and Canada research chair in aquatic health sciences, exploring host pathogens relations in their environment. From 1994 to 2004, Dr. Berthe has led active research in aquatic animal health at the French institute for the exploitation of the sea (IFREMER) in France and overseas territories. Dr. Berthe is vice president of the Biological Standards Commission of OIE. He has served on OIE specialized commissions since 1996. A native of France, Dr. Berthe received a doctorate of veterinary medicine and a Ph.D. degree in molecular parasitology. He has a diploma in bacteriology from the Pasteur Institute.
Helen W. Boucher, M.D., FACP, FIDSA, is the director of the Infectious Diseases Fellowship Program at Tufts Medical Center and professor of medicine at the Tufts University School of Medicine. Dr. Boucher’s clinical interests include infections in immunocompromised patients and S. aureus infections. Her research interests focus on S. aureus and the development of new anti-infective agents. She is the author or co-author of numerous abstracts, chapters, and peer-reviewed articles, which have been published in such journals as the New England Journal of Medicine, Antimicrobial Agents and Chemotherapy, Clinical Infectious Diseases, and the Annals of Internal Medicine; she is associate editor of Antimicrobial Agents and Chemotherapy. She has been included in “Best Doctors in America” since 2009. In 2011, Dr. Boucher was elected fellow and member of the Board of Directors of the Infectious Diseases Society of America (IDSA). In 2012, she was elected to the American Board of Internal Medicine Infectious Disease Exam Writing Committee and in 2014, to the American Board of Internal Medicine Infectious Diseases Subspecialty Board. In 2015, she was appointed to the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, and elected treasurer of IDSA. She was awarded the IDSA Society Citation Award in October 2015. Dr. Boucher serves on the Board of Trustees of the Physicians of Tufts Medical Center and the College of the Holy Cross.
Stephen Brooks, B.Sc., joined Pfizer Inc. as a discovery chemist in the United Kingdom in 1982. He moved into health and safety in 1989 and
has held positions of increasing responsibilities in the company’s Environment, Health, and Safety (EHS) organization in the European Union, United Kingdom, and the United States. Mr. Brooks has led Pfizer’s Global EHS organization since 2007 when he also assumed responsibility for Business Resiliency, Environmental Sustainability, and Quality Audit (cGMP) for the company. Mr. Brooks and his leadership team are responsible for developing strategy, policies, and standards, and for driving continuous improvement in the management of relevant risk across all Pfizer divisions and locations. Mr. Brooks is also responsible for monitoring and where appropriate, seeking to influence the external environment on EHS matters of importance to the company, as well as the biopharmaceutical industry. In this capacity, Mr. Brooks is a committee member of relevant trade associations and other external organizations. He holds an honors degree in chemistry from Bath University, UK, is a chartered safety practitioner (UK), and is a professional member of the American Society of Safety Engineers.
Paula J. F. Cray, Ph.D., is a professor and head of the Department of Population Health and Pathobiology at the College of Veterinary Medicine, North Carolina State University-Raleigh (2014 to present). Prior, she was a microbiologist and research leader for the U.S. Department of Agriculture’s Agricultural Research Service (USDA-ARS) for 24 years. From 1997 to 2012, she served as the director of the animal arm of the National Antimicrobial Resistance Monitoring System (NARMS) and the director of USDA VetNet (PulseNet equivalent) from 2003 to 2014. Dr. Cray served on numerous World Health Organization (WHO) expert working groups and continues service as a member of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance, which includes serving as a lead mentor for developing countries implementing WHO surveillance programs. Currently, she is leading an expansion of global research efforts in the department that involves Africa, China, and India. Dr. Cray’s current research continues to focus on the global ecology and impact of antimicrobial resistance from a One Health perspective. She holds a bachelor of science degree from The Pennsylvania State University, a master of science degree from North Dakota State University (bacteriology), a master in administrative sciences from Johns Hopkins University (administration), and a Ph.D. from the University of Nebraska Medical School. She has received numerous national and international awards, published more than 195 peer-reviewed papers, and given more than 210 invited presentations and interviews.
Gregory W. Daniel, Ph.D., M.P.H., R.Ph., is the deputy director of the Duke-Robert J. Margolis, M.D., Center for Health Policy and a clinical professor in Duke’s Fuqua School of Business. Dr. Daniel directs the Wash-
ington, DC-based office of the center and leads the center’s pharmaceutical and medical device policy portfolio, which includes developing policy and data strategies for improving development and access to innovative pharmaceutical and medical device technologies. This includes post-market evidence development to support increased value, improving regulatory science and drug development tools, optimizing biomedical innovation, and supporting drug and device value-based payment reform. Dr. Daniel is also adjunct associate professor in the Division of Pharmaceutical Outcomes and Policy at the University of North Carolina Eshelman School of Pharmacy. Previously, he was the managing director for evidence development and biomedical innovation in the Center for Health Policy, a fellow in economic studies at the Brookings Institution, and vice president of government and academic research at HealthCore (an Anthem, Inc., company). In addition to health and pharmaceutical policy, Dr. Daniel’s research expertise includes real-world evidence development using electronic health data in the areas of health outcomes and pharmacoeconomics, comparative effectiveness, and drug safety and pharmacoepidemiology. Dr. Daniel received a Ph.D. in pharmaceutical economics, policy, and outcomes from the University of Arizona, as well as an M.P.H., M.S., and B.S. in Pharmacy, all from The Ohio State University.
Sally Davies, FRS, FMedSci, is the chief medical officer for England and chief medical advisor to the UK government. She advises on medical matters with particular responsibilities for public health providing leadership to public health directors. She founded the National Institute for Health Research and was the Department of Health’s chief scientific advisor and research and development lead. Professor Davies is a member of several prominent international advisory committees and sat on the World Health Organization (WHO) Executive Board. Her 2013 Annual Report highlighted the increasing threat from antimicrobial resistance (AMR) and called for global action to address this. She continues to advocate globally on AMR. She chaired the World Innovation Summit for Heath 2013 AMR forum and chairs the WHO AMR Strategic and Technical Advisory Group. She raised public awareness of AMR through a Penguin book and a TED talk. Professor Davies is a fellow of The Royal Society and a member of the U.S. National Academy of Medicine.
Jeffrey S. Duchin, M.D., is a health officer and the chief of the Communicable Disease Epidemiology and Immunization Section for Public Health in Seattle and King County, Washington, and professor of medicine, Division of Infectious Diseases and adjunct professor in the School of Public Health at the University of Washington. Dr. Duchin trained in internal medicine at Thomas Jefferson University Hospital. He completed a fellowship in general
internal medicine and emergency medicine at the Hospital of the University of Pennsylvania and infectious disease subspecialty training at the University of Washington. After several years on the faculty at the University of Pennsylvania, he joined the U.S. Centers for Disease Control and Prevention’s (CDC’s) Epidemic Intelligence Service program where he was assigned to the National Center for Infectious Diseases, and CDC’s Preventive Medicine Residency program. He worked for CDC as a medical epidemiologist in the Divisions of Tuberculosis Elimination and HIV/AIDS Special Studies Branch before assuming his current position. Dr. Duchin is a member of CDC’s Board of Scientific Counselors, Office of Infectious Diseases, and past member of the Advisory Committee on Immunization Practices. He is a fellow of the Infectious Diseases Society of America (IDSA) and has chaired IDSA’s Public Health Committee and the Bioemergencies Task Force. Dr. Duchin serves on the Editorial Board and Technical Advisory Group for Communicable Disease Alert and Response to Mass Gatherings for the World Health Organization and previously served as a member of the U.S. Department of Health and Human Services 2004 Tiger Team, consulting with the government of Greece on health preparations for the 2004 Olympics, in Athens, Greece. Dr. Duchin’s peer-reviewed publications and research interests focus on communicable diseases of public health significance, and he has authored textbook chapters on outbreak investigations, bioterrorism, and the epidemiology of HIV/AIDS.
Lisa Durso, Ph.D., is a microbiologist working for the U.S. Department of Agriculture’s Agricultural Research Service (USDA-ARS), in Lincoln, Nebraska. She began her career in state and federal public health, including 1 year spent as an Emerging Infectious Disease Training fellow at the Foodborne and Diarrheal Disease Branch of the U.S. Centers for Disease Control and Prevention in Atlanta, Georgia, and employment in the Rabies and Arbovirus unit of the Texas Department of Health and molecular diagnostics at the Iowa State Hygienic Laboratory. Following her Ph.D. in food safety microbiology, Dr. Durso worked as a postdoctoral researcher in the Animal Health unit of the USDA Meat Animal Research Center where her work focused on the microbial ecology of E. coli O157:H7 in beef cattle. Her current assignment in Lincoln focuses on environmental components of microbes in manure, including pathogens, fecal indicators, and antibiotic-resistant bacteria, as well as contributions of manure microbial communities to soil health and nutrient cycling.
Victor J. Dzau, M.D., is the president of the National Academy of Medicine. In addition, he serves as chair of the Health and Medicine Division Committee of the National Academies of Sciences, Engineering, and Medicine. He is chancellor emeritus and James B. Duke Professor of Medicine
at Duke University and the past president and chief executive officer of the Duke University Health System. Previously, Dr. Dzau was the Hersey Professor of Theory and Practice of Medicine and chairman of medicine at Harvard Medical School’s Brigham and Women’s Hospital, as well as chairman of the Department of Medicine at Stanford University. Dr. Dzau has made a significant impact on medicine through his seminal research in cardiovascular medicine and genetics, his pioneering of the discipline of vascular medicine, and his leadership in health care innovation. His important work on the renin angiotensin system (RAS) paved the way for the contemporary understanding of RAS in cardiovascular disease and the development of RAS inhibitors as widely used, lifesaving drugs. Dr. Dzau also pioneered gene therapy for vascular disease, and his recent work on stem cell paracrine mechanisms and the use of microRNA in direct reprogramming provides novel insight into stem cell biology and regenerative medicine. As one of the world’s preeminent academic health leaders, Dr. Dzau advises governments, corporations, and universities worldwide. He has been a member of the Council of the IOM and the Advisory Committee to the director of the National Institutes of Health (NIH), as well as chair of the NIH Cardiovascular Disease Advisory Committee and the Association of Academic Health Centers. He served on the Governing Board of the Duke-National University of Singapore Graduate Medical School and the Board of Health Governors of the World Economic Forum and chaired its Global Agenda Council on Personalized and Precision Medicine. He also served as the senior health policy advisor to Her Highness Sheikha Moza (chair of the Qatar Foundation). Currently, he is a member of the Board of Directors of the Singapore Health System; the Expert Board of the Imperial College Health Partners, UK; and the International Advisory Board of the Biomedical Science Council of Singapore. In 2011, he led a partnership among Duke University, the World Economic Forum, and McKinsey, and he founded the International Partnership for Innovative Healthcare Delivery and currently chairs its Board of Directors.
Emily Erbelding, M.D., M.P.H., is the director of the Division of Microbiology and Infectious Diseases (DMID) at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). She is responsible for the strategic and scientific vision for DMID’s complex national and international research program. DMID supports basic, preclinical, and clinical investigations into the causes, diagnosis, treatment, and prevention of a broad range of pathogens, including those related to biodefense and emerging infectious diseases. Prior to joining DMID in 2017, Dr. Erbelding served as deputy director of the Division of AIDS at NIAID, spent 14 years on the faculty of the Johns Hopkins University School of Medicine, in the Division of Infectious Diseases, and was
the director of Clinical Services for the Baltimore City Health Department STD (sexually transmitted disease)/HIV program. Dr. Erbelding received her bachelor’s and master’s degrees from Cornell University and her medical degree from Indiana University School of Medicine. She completed her residency in internal medicine at Northwestern University Medical Center and earned a Master of Public Health degree from the Johns Hopkins Bloomberg School of Public Health. Since 2011, Dr. Erbelding has served as an attending physician for a weekly half-day infectious disease clinic at the Veterans Affairs Medical Center in Washington, DC. She is certified by the American Board of Internal Medicine as a Diplomate of Infectious Disease.
Keiji Fukuda, M.D., M.P.H., is the director and a clinical professor at the University of Hong Kong School of Public Health. He previously worked at the World Health Organization (WHO) in several capacities including assistant director-general (ADG) and special representative of the director-general for antimicrobial resistance; ADG for the Health Security and Environment Cluster; and director of the Global Influenza Programme. Before that, he worked at the U.S. Centers for Disease Control and Prevention (CDC) as the Epidemiology Section chief, Influenza Branch, and as a medical epidemiologist in the Viral Exanthems and Herpesvirus Branch, National Center for Infectious Diseases. Dr. Fukuda has been a global public health leader in many areas, including health security; emerging infectious diseases, including seasonal, avian and pandemic influenza, severe acute respiratory syndrome, Middle East respiratory syndrome, and Ebola; antimicrobial resistance; development of the Pandemic Influenza Preparedness Framework; implementation of the International Health Regulations; food safety; and chronic fatigue syndrome. He has considerable experience in epidemiological research and field investigations, media communications, and international diplomatic negotiations, including those held to establish a historic heads of state-level meeting on antimicrobial resistance at the United Nations in 2016. He has a B.A. in biology, an M.D., an M.P.H., was trained in the Epidemic Intelligence Service at CDC, and is certified in internal medicine by the American Board of Internal Medicine.
James M. Hughes, M.D., is a professor of medicine and public health, with joint appointments in the School of Medicine (infectious diseases) and the Rollins School of Public Health (global health), at Emory University and the co-director of the Emory Antibiotic Resistance Center. Prior to joining Emory in June 2005, Dr. Hughes worked at the U.S. Centers for Disease Control and Prevention (CDC), serving as director of the National Center for Infectious Diseases (NCID) and as a rear admiral and an assistant surgeon general in the U.S. Public Health Service. He first joined CDC as a member of the Epidemic Intelligence Service in 1973. He served as director
of CDC’s Hospital Infections Program from 1983 to 1988, as NCID deputy director from 1988 to 1992, and as NCID director from 1992 to 2005. Dr. Hughes received his B.A and M.D. from Stanford University and completed his postgraduate training and board certification in internal medicine (University of Washington), infectious diseases (University of Virginia), and preventive medicine (CDC). He is a member of the National Academy of Medicine and a fellow of the Infectious Diseases Society of America (IDSA), the American Society of Tropical Medicine and Hygiene, the American Academy of Microbiology, and the American Association for the Advancement of Science. He has served on the Forum on Microbial Threats since 1996 and as vice chair of the Forum since 2009. He served on the Board of Directors of IDSA from 2004 to 2007 and as IDSA President from 2010 to 2011. He is currently a member of the Board of Directors of the American Academy of Microbiology, the One Health Commission, and the EcoHealth Alliance. Among his honors and awards are the Distinguished and Meritorious Service Medals and the Surgeon General’s Exemplary Service Award from the U.S. Public Health Service, the Secretary’s Open Forum Distinguished Public Service Award from the U.S. Department of State, the CDC Lifetime Scientific Achievement Award, the Gen–Probe Joseph Award from the American Society for Microbiology for “exemplary leadership and service in the field of public health,” the Jonathan M. Mann Lectureship Award from the Council of State and Territorial Epidemiologists, the Bailey K. Ashford Memorial Lecturer at the University of Puerto Rico School of Medicine, and membership in the Emory Millipub Club. Dr. Hughes has published more than 110 research articles, 10 reviews, 15 editorials, and 45 book chapters. He has co-edited 10 books on emerging infectious diseases.
Timothy Johnson, Ph.D., is an associate professor of microbiology at the University of Minnesota. He received his Ph.D. in molecular pathogenesis from North Dakota State University in 2004, followed by postdoctoral studies at Iowa State University College of Veterinary Medicine. Dr. Johnson joined the University of Minnesota Department of Veterinary and Biomedical Sciences in 2007. He has since developed an internationally recognized research and outreach program focused on the genetic mechanisms enabling the spread of antibiotic resistance in Enterobacteriaceae. In tandem, his work focuses on the identification of antibiotic alternatives that manipulate the animal microbiome allowing for enhanced growth and reduced disease. He also currently serves as director of research and development at the Mid-Central Research and Outreach Center’s Poultry Research Laboratory in Willmar, Minnesota.
Kent E. Kester, M.D., is currently the vice president and head of Translational Science and Biomarkers at Sanofi Pasteur. During a 24-year career
in the U.S. Army, he worked extensively in clinical vaccine development and led multiple research platforms at the Walter Reed Army Institute of Research, the U.S. Department of Defense’s largest and most diverse biomedical research laboratory—an institution he later led as its commander/director. His final military assignment was as the associate dean for clinical research in the School of Medicine at the Uniformed Services University of the Health Sciences (USUHS). Dr. Kester holds an undergraduate degree from Bucknell University and an M.D. from Jefferson Medical College. He completed his internship and residency in internal medicine at the University of Maryland and a fellowship in infectious diseases at the Walter Reed Army Medical Center. A malaria vaccine researcher with more than 70 scientific manuscripts and book chapters, Dr. Kester has played a major role in the development of the malaria vaccine candidate known as RTS,S. Currently a member of the U.S. Government Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, he previously chaired the Steering Committee of the National Institute of Allergy and Infectious Diseases (NIAID)-USUHS Infectious Disease Clinical Research Program, and has served as a member of the U.S. Food and Drug Administration’s Vaccines and Related Biologics Products Advisory Committee, the NIAID Advisory Council, and the U.S. Centers for Disease Control and Prevention’s Office of Infectious Diseases Board of Scientific Counselors. Board certified in both internal medicine and infectious diseases, he holds faculty appointments at USUHS and the University of Maryland. He is a fellow of the American College of Physicians, the Infectious Diseases Society of America, and the American Society of Tropical Medicine and Hygiene.
Rima F. Khabbaz, M.D., is the deputy director for infectious diseases and director of the Office of Infectious Diseases at the U.S. Centers for Disease Control and Prevention (CDC). Prior to her current position, she served as the director of CDC’s National Center for Preparedness, Detection, and Control of Infectious Diseases and held other leadership positions across the agency’s infectious disease national centers. She is a graduate of the American University of Beirut, Lebanon, where she obtained both her bachelor’s degree in science and her medical doctorate degree. She trained in internal medicine and completed a fellowship in infectious diseases at the University of Maryland, Baltimore. She joined CDC in 1980 as an Epidemic Intelligence Service officer, working in the Hospital Infections Program. During her CDC career, she has made major contributions to advance infectious disease prevention, including leadership in defining the epidemiology of non-HIV retroviruses (HTLV-I and II) in the United States and developing guidance for counseling HTLV-infected persons, establishing national surveillance for hantavirus pulmonary syndrome following the 1993 U.S. outbreak, and developing CDC’s blood safety and food safety programs
related to viral diseases. She has also played key roles in CDC’s responses to outbreaks of new and/or reemerging viral infections, including Nipah, Ebola, West Nile, severe acute respiratory syndrome, and monkey pox, as well as the 2001 anthrax attacks. She is a fellow of the Infectious Diseases Society of America (IDSA) and member of the American Epidemiologic Society, the American Society for Microbiology, the Council of State and Territorial Epidemiologists, and the American Society for Tropical Medicine and Hygiene. She served on IDSA’s Annual Meeting Scientific Program Committee and currently serves on the society’s Public Health Committee. In addition to her CDC position, she serves as adjunct professor of medicine (infectious diseases) at Emory University. She is a graduate of the National Preparedness Leadership Initiative at Harvard University and of the Public Health Leadership Institute at the University of North Carolina.
Lonnie King, D.V.M., M.S., M.P.A., is the professor and dean emeritus of the College of Veterinary Medicine at The Ohio State University (OSU). In addition to leading this college, Dr. King is also a professor of preventive medicine and holds the Ruth Stanton Endowed Chair in Veterinary Medicine. He also serves as the executive dean for the seven health science colleges at OSU. Before becoming dean at OSU, he was the director of the new National Center for Zoonotic, Vector-Borne, and Enteric Diseases (NCZVED) at the U.S. Centers for Disease Control and Prevention (CDC). In this new position, Dr. King leads the center’s activities for surveillance, diagnostics, disease investigations, epidemiology, research, public education, policy development, and disease prevention and control programs. NCZVED also focuses on waterborne, foodborne, vector-borne, and zoonotic diseases of public health concern, which include most of the CDC’s select and bioterrorism agents, neglected tropical diseases, and emerging zoonoses. Before serving as director, he was the first chief of the agency’s Office of Strategy and Innovation. Dr. King was in private veterinary practice for 7 years in Dayton, Ohio, and Atlanta, Georgia. As a native of Wooster, Ohio, Dr. King received his bachelor of science and doctor of veterinary medicine degrees from OSU in 1966 and 1970, respectively. He earned his master of science degree in epidemiology from the University of Minnesota and received his master of public administration degree from American University in Washington, DC, in 1991. Dr. King is a board-certified member of the American College of Veterinary Preventive Medicine and has completed the senior executive fellowship program at Harvard University. He served as president of the Association of American Veterinary Medical Colleges from 1999 to 2000 and was the vice chair for the National Commission on Veterinary Economic Issues from 2000 to 2004.
Darrell G. Kirch, M.D., is the president and chief executive officer of the Association of American Medical Colleges (AAMC), which represents the nation’s medical schools, teaching hospitals, and academic medical societies. A distinguished physician, educator, and medical scientist, Dr. Kirch speaks and publishes widely on the need for transformation in the nation’s health care system and how academic medicine can lead change across medical education, biomedical research, and patient care. Prior to becoming AAMC president in 2006, Dr. Kirch served as the dean and academic health system leader of two institutions, the Medical College of Georgia and the Penn State Milton S. Hershey Medical Center. He has co-chaired the Liaison Committee on Medical Education, the accrediting body for U.S. medical schools, and chaired the Washington Higher Education Secretariat. Dr. Kirch also is a member of the National Academy of Medicine. A psychiatrist and clinical neuroscientist by training, Dr. Kirch began his career at the National Institute of Mental Health, becoming the acting scientific director in 1993, and receiving the Outstanding Service Medal of the U.S. Public Health Service. A native of Denver, he earned his B.A. and M.D. degrees from the University of Colorado.
Keith Klugman, Ph.D., leads the Bill & Melinda Gates Foundation’s work to improve the development and delivery of pneumonia vaccines and expand the use of antibiotic treatments and diagnostic tools. Dr. Klugman is a leading expert on antibiotic resistance in pneumonia pathogens and helped develop the pneumococcal vaccine that is part of the immunization regimen for children born in the United States, which is also being rolled out globally. Dr. Klugman previously served as a professor of global health and professor of epidemiology in the Rollins School of Public Health at Emory University and professor of medicine in the Division of Infectious Diseases at the Emory School of Medicine. He serves as an honorary professor in the Respiratory and Meningeal Pathogens Research Unit at the University of the Witwatersrand in South Africa and is a member of the National Academy of Medicine.
Jeffrey A. Linder, M.D., M.P.H., FACP, is a general internist and primary care clinician-investigator. Dr. Linder is the chief of the Division of General Internal Medicine and Geriatrics and the Michael A. Gertz Professor of Medicine at the Northwestern University Feinberg School of Medicine. His research focuses on the care of ambulatory patients with acute respiratory infections—the number one symptomatic reason for seeking medical care in the United States—and the appropriate use of antibiotics in ambulatory care. Dr. Linder has expertise in electronic health records and clinical decision support, as well as using behavioral science and social psychology
to understand and change behavior. Dr. Linder serves on the Outpatient Antibiotic Use Target-Setting Workgroup, which was convened by the U.S. Centers for Disease Control and Prevention and The Pew Charitable Trusts; the Antibiotic Stewardship Research Workshop Planning Committee of the Society for Healthcare Epidemiology of America; and is a standing member of the Agency for Healthcare Research and Quality’s Healthcare Safety and Quality Improvement Study Section. Dr. Linder received his medical degree from Northwestern University Feinberg School of Medicine and a Master of Public Health degree from the Harvard T.H. Chan School of Public Health.
Andrew T. Maccabe, D.V.M., M.P.H., J.D., is the chief executive officer of the Association of American Veterinary Medical Colleges (AAVMC). He received his bachelor of science and doctor of veterinary medicine degrees from The Ohio State University in 1981 and 1985, respectively and began his professional career in a mixed animal practice with primary emphasis on dairy herd health. In 1988, he was commissioned as a public health officer in the U.S. Air Force where he managed the preventive medicine activities of several Air Force installations and directed programs in occupational health, communicable disease control, and health promotion. Dr. Maccabe completed his master of public health degree at Harvard University in 1995. That same year he became chief of the Health Risk Assessment Branch of the U.S. Air Force where he directed the health risk assessment program for environmental restoration activities throughout the Air Force. Dr. Maccabe completed his juris doctor degree, magna cum laude, at the University of Arizona in 2002 and subsequently became the associate executive director at the Association of American Veterinary Medical Colleges where he led programs to advance veterinary medical education. In 2007, he was appointed as U.S. Centers for Disease Control and Prevention’s Liaison to the Food and Drug Administration, where he coordinated policies and programs between the two agencies before returning to AAVMC in 2012 as the chief executive officer.
Patrick McDermott, Ph.D., is the director of the National Antimicrobial Resistance Monitoring System (NARMS) at the U.S. Food and Drug Administration (FDA). NARMS was established in 1996 and is a One Health interagency effort among FDA, the U.S. Department of Agriculture (USDA), and the U.S. Centers for Disease Control and Prevention (CDC) that tracks antibiotic resistance in food-borne bacteria. He is past director of the Division of Animal and Food Microbiology and past deputy director of the Office of Research in the Office of Research at FDA’s Center for Veterinary Medicine. Dr. McDermott is a founding member of the World Health Organization (WHO) Advisory Group on Integrated Surveillance of Antimicrobial Resistance and serves on the steering Committee of the
WHO Global Foodborne Infections Network. He represents FDA on the Transatlantic Task Force on Antimicrobial Resistance and the National Science and Technology Subcommittee on Food and Agriculture, devising a pathway for sustainable agriculture in the United States. Dr. McDermott is the 2016 recipient of the Francis Kelsey Award for Excellence and Courage in Protecting the Public Health. He is a microbiologist by training who has studied antimicrobial resistance for 25 years.
L. Clifford McDonald, M.D., is an internationally recognized expert on the epidemiology and prevention of health care–associated infections and antibiotic resistance, with particular expertise in the epidemiology, diagnosis, and prevention of Clostridium difficile infections. He is the author or coauthor of more than 150 peer-reviewed publications and book chapters on these subjects. Dr. McDonald is currently the associate director for science in the Division of Healthcare Quality Promotion at the U.S. Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia. Dr. McDonald graduated from the Northwestern University Medical School, completed his internal medicine residency at Michigan State University, and an infectious diseases fellowship at the University of South Alabama, following which he completed a fellowship in medical microbiology at Duke University. Past positions have included associate investigator at the National Health Research Institutes in Taiwan, where he assisted in the development of an island-wide antibiotic resistance monitoring program, and assistant professor in the Division of Infectious Diseases at the University of Louisville, where he served as health care epidemiologist. Dr. McDonald is a former officer in CDC’s Epidemic Intelligence Service and former chief of the Prevention and Response Branch, as well as former senior advisor for science and integrity in the Division of Healthcare Quality Promotion at CDC.
Suerie Moon, Ph.D., M.P.A., is the director of research at the Global Health Centre, Graduate Institute of International and Development Studies, Geneva, Switzerland, and adjunct lecturer on global health at the Harvard T.H. Chan School of Public Health. She has served on a number of advisory bodies, including most recently the World Health Organization Fair Pricing Forum Advisory Group, Expert Advisory Group to the United Nations Secretary-General’s High-Level Panel on Access to Medicines, and Proposal Review Committee of UNITAID. Prior to joining the Graduate Institute, she was study director of the Harvard-London School of Hygiene & Tropical Medicine Independent Panel on the Global Response to Ebola, and co-founded and led the Forum on Global Governance for Health, a focal point at Harvard University for research, debate, and strategic convening on issues at the intersection of global governance and health. Her research and teaching focus on global governance, the political economy of global
health (focusing on innovation and access to medicines; outbreak preparedness and response; trade, investment, and intellectual property rules; and development assistance for health), the evolution of international regimes, and innovative policies for addressing global problems. She received a B.A. from Yale, an M.P.A. from Princeton, and a Ph.D. from the Harvard Kennedy School of Government.
Robert D. Newman, M.D., M.P.H., is the global head of TB Programs within the Global Public Health group at Johnson & Johnson, where he leads a team focused on accelerating the company’s ongoing efforts toward ending tuberculosis (TB). From 2015 to 2017, Dr. Newman was the Cambodia country director for the U.S. Centers for Disease Control and Prevention (CDC), overseeing activities related to HIV/AIDS, TB, malaria, health security, outbreak response, health systems strengthening, and capacity building. From 2014 to 2015, Dr. Newman served as managing director for Policy and Performance at Gavi, the Vaccine Alliance, in Geneva, Switzerland. In that role, he oversaw organizational strategy setting, performance metrics, market shaping, policy development, business planning, monitoring and evaluation, and risk management. From 2009 to 2014, he was the director of the Global Malaria Program at the World Health Organization in Geneva. From 2000 to 2009, Dr. Newman served in the U.S. Public Health Service, and was assigned to the Malaria Branch at CDC, where he led the CDC team for the U.S. President’s Malaria Initiative from 2006 to 2009. He has also spent time in the field in South America and Africa, first studying Cryptosporidium in a favela in Brazil in the early 1990s, and then as country coordinator of Health Alliance International in Mozambique in the late 1990s supporting the government in its efforts to improve maternal and child health. He received his B.A. in English literature from Williams College, his M.D. from Johns Hopkins University, and his M.P.H. from the University of Washington. Dr. Newman is a board-certified pediatrician; he completed his residency in pediatrics at the University of Washington’s Seattle Children’s Hospital in 1996, and stayed on to complete a National Research Service Award fellowship in general pediatrics in 1998. He has published more than 65 peer-reviewed articles on infectious diseases.
Lance Price, Ph.D., is a professor at The George Washington University’s Milken Institute School of Public Health in Washington, DC. He is also the founding director of the Antibiotic Resistance Action Center. Dr. Price works at the interface between science and policy to address the growing crisis of antibiotic resistance. In the laboratory, Dr. Price uses cutting-edge molecular approaches to trace the origins of antibiotic-resistant bacteria and develop strategies to block their transmission. In the policy arena,
Dr. Price works with nongovernmental organizations and policy makers to develop science-based policies to curb antibiotic abuse in food-animal production. Dr. Price’s works have been covered in media outlets around the world. Dr. Price has a bachelor’s and master’s degree from the Department of Biology at Northern Arizona University and a Ph.D. from the Johns Hopkins Bloomberg School of Public Health.
David A. Relman, M.D., is the Thomas C. and Joan M. Merigan Professor in the Departments of Medicine and of Microbiology and Immunology at Stanford University, and chief of infectious diseases at the Veterans Affairs Palo Alto Health Care System in Palo Alto, California. He is also co-director of the Center for International Security and Cooperation and senior fellow at the Freeman Spogli Institute for International Studies at Stanford University. Dr. Relman was an early pioneer in the application of molecular methods for studying the human indigenous microbiota. Most recently, his work has focused on human microbial community assembly, and community stability and resilience in the face of disturbance. Previous work included the development of molecular methods for identifying novel microbial pathogens and the subsequent identification of several historically important microbial disease agents, as well as molecular mechanisms of bacterial pathogenesis. One of his papers was selected as “1 of the 50 most important publications of the past century” by the American Society for Microbiology. Dr. Relman received an S.B. (biology) from the Massachusetts Institute of Technology, an M.D. from Harvard Medical School, and joined the faculty at Stanford in 1994. He is currently a member of the Board of Scientific Counselors for the National Center for Biotechnology Information at the National Institutes of Health (NIH). Besides serving on the National Academies of Sciences, Engineering, and Medicine’s Forum on Microbial Threats, he is a member of the Committee on Science, Technology and Law, and a member of the Intelligence Community Studies Board, both at the National Academies, and advises several U.S. government agencies on current and future microbial threats. He previously served as vice chair of the National Academies committee that reviewed the science performed as part of the Federal Bureau of Investigation’s inquiry of the 2001 anthrax letters, as a member of the National Science Advisory Board on Biosecurity (2005 to 2014), and as president of the Infectious Diseases Society of America (2012 to 2013). He received an NIH Pioneer Award in 2006, an NIH Transformative Research Award in 2011, and was elected a member of the National Academy of Medicine in 2011.
John H. Rex, M.D., is a physician and drug developer with 30 years of development and policy experience focused on antimicrobial agents. His experience includes moving compounds from early preclinical development
through all development phases in the context of academic positions, vice president-level roles at AstraZeneca, board-level roles in biotech companies, and operating partner role with a venture capital group. He also is currently a voting member of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria.
Peter A. Sands, M.P.A., is a senior fellow at the Mossavar-Rahmani Center for Business and Government at Harvard Kennedy School, where he is working on a range of research projects in financial markets and regulation, financial technology, and global health. He is chair of the International Working Group on Financing Preparedness and Response Commission, which is supported by the World Bank and the Wellcome Foundation, and he also chaired the International Commission on a Global Health Risk Framework for the Future under the auspices of the National Academy of Medicine. Mr. Sands has published several papers on global health issues in journals such as the New England Journal of Medicine and The Lancet. He is also the lead nonexecutive director of the Department of Health in the United Kingdom. Mr. Sands is a board member or advisor to several startups in the financial technology and medical technology arenas, such as Noble Markets (United States) and Cera (United Kingdom). Mr. Sands was group chief executive of Standard Chartered PLC from November 2006 to June 2015. He joined the board of Standard Chartered PLC as group finance director in May 2002, responsible for Finance, Strategy, Risk, and Technology and Operations. Prior to this, he was director and senior partner at worldwide consultants McKinsey & Co. Before joining McKinsey, Mr. Sands worked for the UK Foreign and Commonwealth Office. He has served on various boards and commissions, including as a director of the World Economic Forum and co-chairman of Davos; governor of the UK National Institute for Economic and Social Research; member of the International Advisory Board of the Monetary Authority of Singapore; member of the Browne Commission on Higher Education Funding in the United Kingdom; member of the China People’s Association for Friendship with Foreign People’s Global CEO Council, co-chair of the UK-India CEO Forum; board director of the Institute of International Finance; chairman of the International Monetary Conference; member of the International Advisory Board of Lingnan University, China; and trustee of the Camden Roundhouse, London. Mr. Sands graduated from Brasenose College, Oxford University, with a First Class degree in Politics, Philosophy, and Economics. He also received a Master in Public Administration from Harvard University, where he was a Harkness Fellow.
H. Morgan Scott, D.V.M., Ph.D., is a graduate veterinarian holding a Ph.D. in epidemiology and postdoctoral training in public health. In addition to
private veterinary practice, he has worked in both government (food safety surveillance) and academic settings. He is currently professor of epidemiology in the Department of Veterinary Pathobiology at Texas A&M University. He was recruited there in 2014 as part of the Texas A&M University System Chancellor’s Research Initiative and the University President’s Initiative on One Health and Infectious Diseases. He relocated from Kansas State University, where he previously held the E.J. Frick Professorship in veterinary medicine. Much of his research emphasis has been on studying factors affecting antimicrobial resistance among commensal and pathogenic enteric bacteria in food animal production systems, with a program spanning the realm from the molecular to the sociological. In particular, he is interested in applying both epidemiological and ecological approaches to quantify the emergence, propagation, dissemination, and persistence of resistant enteric bacterial strains in integrated populations of animals, their food products, and humans. Using this knowledge, he hopes to identify opportunities to prevent and intervene against resistance among enteric pathogens in animal agriculture, preferably by developing readily adoptable and cost-effective management practices suited to modern animal and food production systems.
Angela Siemens, Ph.D., is the vice president of food safety, quality, and regulatory for Cargill in Wichita, Kansas. She is responsible for food safety issues and quality management systems and processes in approximately 40 beef, turkey, egg, case-ready, and processing facilities in North America. She also oversees the food safety issues of meat co-packers and meat and ingredient suppliers. Dr. Siemens served as Beef Industry Food Safety Council chairman in 2014 to 2015. Prior to her tenure at Cargill, she worked as vice president of food safety and technical services for Smithfield Packing Company in Smithfield, Virginia. She also worked at the Oscar Mayer Foods Division of Kraft Foods in Madison, Wisconsin, and Beatrice Cheese. She served 1 year as a Congressional Science Fellow to the U.S. House of Representatives Committee on Agriculture in Washington, DC. The National Provisioner named her as 1 of “25 Future Icons.” Dr. Siemens received a Ph.D. in meat science and an M.S. in animal science from the University of Missouri, Columbia, and a B.S. in animal science from Purdue University, West Lafayette, Indiana. She received the 2010 Purdue University College of Agriculture Distinguished Alumni award.
Jeffrey Silverstein, Ph.D., is the deputy administrator for animal production and protection with the Office of National Programs at the U.S. Department of Agriculture’s Agricultural Research Service (USDA-ARS). He started in this position in October 2016. In his 20-year career with ARS, Dr. Silverstein has held a variety of positions, as research geneticist and
administrator including both National Program and Area Office capacities. He earned a B.A. in biology and East Asian studies from Colgate University and after a stint working on an oyster farm, he began graduate studies in aquaculture at the University of Washington. He received his Ph.D. in fisheries genetics in 1993. He completed a postdoctoral fellowship at the Japanese National Research Institute for Aquaculture (Mie, Japan) and returned to the United States as a research faculty at University of Washington in the fish physiology program. He joined USDA-ARS in 1997 as a research geneticist, and his research focused on physiology and selective breeding of finfish, particularly for improved growth, feed efficiency, use of alternative feeds, and disease resistance. In 2011, he worked with the U.S. Agency for International Development on research aspects of the Feed the Future Initiative with the Bureau for Food Security and the Science and Technology group in the Policy, Planning, and Learning Division. In 2013, he served as the acting director for the Office of the Chief Scientist for USDA. He is the author and co-author of more than 85 scientific and technical research publications and has delivered more than 50 invited lectures on animal genetics and genomics in the United States and internationally.
Randall Singer, D.V.M., M.P.V.M., Ph.D., is a professor of epidemiology at the University of Minnesota. He has a dual appointment in the Department of Veterinary and Biomedical Sciences, College of Veterinary Medicine, and the Division of Epidemiology, School of Public Health. Prior to joining the faculty at Minnesota, he was an assistant professor of epidemiology at the University of Illinois at Urbana-Champaign. He received his D.V.M. and M.P.V.M. in 1995 and his Ph.D. in Epidemiology in 1999, all from the University of California, Davis. Dr. Singer has developed an internationally recognized research and educational program focused on predicting the emergence, spread, and persistence of infectious diseases. In 2000, he was awarded the Presidential Early Career Award for Scientists and Engineers by President Clinton for his work on antibiotic resistance. Since that time, he has devoted most of his research program to understand the emergence, spread, and persistence of antimicrobial resistance. In 2005, he was selected as a McKnight Land-Grant Professor at the University of Minnesota, a distinguished group of junior faculty within the university, for his work on this topic. Between 2006 and 2010 he served on the U.S. Delegation to the CODEX Task Force on Antimicrobial Resistance. He has spoken twice to the U.S. House of Representatives on this topic and currently serves as a voting member of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria.
David Sjeklocha, D.V.M., is a 1994 graduate of the Kansas State University College of Veterinary Medicine. His entire career has been focused on
helping to produce ethically raised, safe, wholesome beef. Dr. Sjeklocha spent 10 years in mixed animal practice in Kansas and Nebraska. As his practice evolved, he eventually specialized in cattle feed yard veterinary consultation, with a focus on animal welfare and managing cattle health to reduce antimicrobial use. In 2011, he joined Cattle Empire, LLC, a large, family-owned cattle feeding company in southwest Kansas as Operations Manager of Animal Health and Welfare. In this position, he has been able to oversee the development and implementation of cutting-edge efforts to improve animal welfare and animal health management. He firmly beliefs that “use of an antimicrobial is an indication that there has been a breakdown in management.”
Bruce Stewart-Brown, D.V.M., is the senior vice president of live production, food safety, and quality for Perdue Farms, based at the company’s corporate office in Salisbury, Maryland. He is responsible for the food safety and quality programs in all the fresh and cook plants. Mr. Stewart-Brown is also responsible for the company’s chicken live operations, which include parent breeding operations, hatcheries, feed mills, and grow-out management.
Kathy Talkington, M.P.Aff., directs The Pew Charitable Trusts’ work on antibiotics, which seeks to address the growing threat of antibiotic resistance by spurring the innovation of new antibiotics and ensuring the appropriate use of antibiotics in both human health care settings and in food animals. Before joining Pew, Ms. Talkington managed the immunization and infectious disease programs at the Association of State and Territorial Health Offices, where she developed policies on hospital-acquired infections, antimicrobial resistance, and issues related to immunization. Previously, she led strategic initiatives and programs on a wide range of health care issues for numerous nonprofit advocacy organizations and also state and federal policy makers. Ms. Talkington has a bachelor’s degree from the University of Virginia and a master’s degree in public affairs from The University of Texas at Austin.
James M. Tiedje, Ph.D., is a university distinguished professor of microbiology and molecular genetics and of plant, soil, and microbial sciences, and is director of the Center for Microbial Ecology at Michigan State University. His research focuses on microbial ecology, physiology, and diversity, especially regarding the nitrogen cycle, biodegradation of environmental pollutants, and more recently on the use of genomics and metagenomics to understand speciation, community structure, and functions, including antibiotic resistances. He has served as editor-in-chief of Applied and Environmental Microbiology and editor of Microbial and Molecular Biology Reviews. He has more than 500 referenced publications. He served on the
National Academies of Sciences, Engineering, and Medicine’s Board on Life Sciences; the U.S. Environmental Protection Agency’s Science Advisory Panel; and the U.S. Department of Energy’s Biological and Environmental Research Advisory Committee. He was president of the American Society for Microbiology and the International Society of Microbial Ecology. He shared the 1992 Finley Prize from the United Nations Educational, Scientific and Cultural Organization for research contributions in microbiology of international significance and was awarded an Einstein Professorship in 2010 by the Chinese Academy of Sciences. He is a fellow of the American Association for the Advancement of Science, the American Academy of Microbiology, the Soil Science Society of America, the Ecological Society of America, and a member of the U.S. National Academy of Sciences.
Ed Topp, Ph.D., is a native of Montreal and received his Ph.D. from the Department of Microbiology at the University of Minnesota in 1988. Since then, he has toiled as a research scientist with Agriculture and Agri-Food Canada (AAFC) and has adjunct appointments in the Department of Biology at the University of Western Ontario in London, and the Department of Soil and Water Science at the University of Florida. Dr. Topp’s research concerns the interface between agriculture and human and environmental health and has generated more than 250 co-authored publications. In the past decade he has notably led several national studies concerning the fate and management in agro-ecosystems of pathogenic and antibiotic-resistant bacteria carried in animal and human (biosolids) waste. He recently received the AAFC Gold Harvest Award for career achievement and the Canadian Public Service Award for Excellence for research contributions. Dr. Topp is past president (2011) of the Canadian Society of Microbiologists, and over the past several years he has organized a number of international workshops and conference sessions concerning antibiotic resistance, agriculture, and the environment.
Evelyn Wesangula, M.Sc., B.Pharm., is a pharmacist with postgraduate training in tropical and infectious diseases. She currently heads the Antimicrobial Resistance (AMR) Program at the Ministry of Health of the Government of Kenya. Dr. Wesangula has been the coordinator for the Global Antibiotic Resistance Partnership-Kenya (GARP-Kenya) working group for the past 4 years. Through the coordination of GARP, she initiated a platform for information sharing on antimicrobial resistance within the Ministry of Health through the National Infection Prevention and Control Committee, while coordinating the Global AMR week in 2013 and 2014, and advocated for the establishment of the National AMR program and the appointment of the multisectoral members of the National Antimicrobial Stewardship Advisory Committee. Over the past 10 years, Dr. Wesangula
has worked within the public sector and gained an in-depth knowledge on the working of pharmaceutical systems in relation to public health. She has gained competencies in developing and implementing training curricula for different target groups for diseases of public health priority. She has also gained skills in editing scientific papers and report writing and in conducting operational research. As the focal person for AMR, Dr. Wesangula coordinated the establishment of the AMR program at the Ministry of Health in collaboration with the Ministry of Agriculture Livestock and Fisheries and recently led the process of implementation of the Global Action Plan on Antimicrobial Resistance in Kenya resulting in the development of a National Policy and Action Plan for AMR.
Mary E. Wilson, M.D., is an adjunct professor of global health and population at the Harvard T.H. Chan School of Public Health and clinical professor of epidemiology and biostatistics in the School of Medicine at the University of California, San Francisco. Her academic interests include the ecology of infections and emergence of microbial threats, travel medicine, tuberculosis, and vaccines. She received her M.D. from the University of Wisconsin and completed an internal medicine residency and infectious disease fellowship at the Beth Israel Hospital in Boston. She was chief of infectious diseases at Mount Auburn Hospital, a Harvard-affiliated community teaching hospital in Cambridge, Massachusetts, for more than 20 years. She is a fellow in the Infectious Diseases Society of America, the American College of Physicians, and the American Society of Tropical Medicine and Hygiene. She has served on the Advisory Committee on Immunization Practices of the U.S. Centers for Disease Control and Prevention, the Academic Advisory Committee for the National Institute of Public Health in Mexico, and on five committees for the National Academies of Sciences, Engineering, and Medicine. She has worked in Haiti at the Albert Schweitzer Hospital and led the Harvard-Brazil Collaborative Course on Infectious Diseases, taught in Brazil. In 1996 she was a resident scholar at the Bellagio Study Center, Italy, and in 2002 she was a fellow at the Center for Advanced Study in the Behavioral Sciences in Stanford, California. She was a member of the Pew National Commission on Industrial Farm Animal Production, whose report, Putting Meat on the Table: Industrial Farm Animal Production in America, was released in the spring of 2008. She serves as a special advisor to the GeoSentinel Surveillance Network, a global network. She serves on several editorial boards and is an associate editor for NEJM Journal Watch Infectious Diseases. She is the author of A World Guide to Infections: Diseases, Distribution, Diagnosis (Oxford University Press, New York, 1991); senior editor, with Richard Levins and Andrew Spielman, of Disease in Evolution: Global Changes and Emergence of Infectious Diseases (New York Academy of Sciences, 1994); and editor
of the volume New and Emerging Infectious Diseases (Medical Clinics of North America) published in 2008. She served on the Board of Trustees for icddr,b (International Centre for Diarrheal Disease Research, Bangladesh) from 2009 through 2015 and is a member of the FXB-USA Board and the Alliance for the Prudent Use of Antibiotics Board of Directors.